Condition: Atrial Fibrillation · Left Atrial Appendage · Stroke · Sponsor: AuriGen Medical Ltd
Demonstrate the safety and performance of the Zenith LAA Occlusion System and procedure to occlude the Left Atrial Appendage (LAA) from the left atrium (LA) using a minimally invasive technique. Indication - LAA closure in patients with non-valvular atrial fibrillation, with an ostial diameter between 18 mm and 26 mm
This description comes directly from the study's public registry record.
Nuwani Edirisinghe · +447581155987 · nuwani.edirisinghe@aurigenmedical.com
John Thompson · +353 863525057 · john.thompson@aurigenmedical.com
Always discuss trial participation with your own doctor first.
| The Royal Melbourne Hospital | Parkville, Victoria, Australia | Not Yet Recruiting |
| Auckland City Hospital | Auckland, New Zealand | Recruiting |
| Christchurch Hospital | Christchurch, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05951101